Fouqué, Amélie <br/><br/>
Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast Cancers.  [electronic resource] 

 -  Recent patents on anti-cancer drug discovery  2016 
 - 283-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>2212-3970 
<br/><br/><label>Standard No.: </label>10.2174/1574892811666160519113731  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--adverse effects<br/>Clinical Trials as Topic<br/>Drug Discovery<br/>Female<br/>Humans<br/>Molecular Structure<br/>Molecular Targeted Therapy<br/>Phosphatidylinositol 3-Kinase--metabolism<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Protein Kinase Inhibitors--adverse effects<br/>Signal Transduction--drug effects<br/>Structure-Activity Relationship<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Triple Negative Breast Neoplasms--drug therapy